Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 CAD | -5.74% | -2.95% | +447.62% |
May. 22 | Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum | MT |
May. 13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
Evolution of the average Target Price on Medicenna Therapeutics Corp.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Medicenna Therapeutics Corp.
Oppenheimer | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- MDNA Stock
- Consensus Medicenna Therapeutics Corp.